Insilico Medicine Appoints Michael Bayewitch, PhD as Head of BD and Licensing North America (IMAGE)
Caption
The expansion of Dr. Bayewitch’s role is part of Insilico’s evolving BD strategy, focusing on asset partnering and out-licensing.
Credit
Insilico Medicine
Usage Restrictions
none
License
Original content